Great Novel Therapeutics Biotech & Medicals Corp.(TW:7427)
NT$59.50+-0.50 (+2.23%)
TW:7427
Great Novel Therapeutics Biotech & Medicals Corp. Revenue
NT$59.50
At close:+-0.50 (+2.23%)
Great Novel Therapeutics Biotech & Medicals Corp. (7427) Revenue
Great Novel Therapeutics Biotech & Medicals Corp. Revenue
Great Novel Therapeutics Biotech & Medicals Corp. had a revenue of 5.63M in the quarter ending Jun 30, 2026, with 866.67%. This bring the company's revenue in the last twelve months to 6.21M, Increased 415.19%. In the fiscal year ending Dec 31, 2025, Great Novel Therapeutics Biotech & Medicals Corp. had annual revenue of 1.21M with -28.49% growth.
- Revenue (ttm)
- 6.21M
- Revenue Growth
- 248.57%
- P/S Ratio
- 2601.87
- Revenue/Employee
- TWD 52,391
- Employees
- 23
- Market Cap
- TWD 3.14B
Revenue Chart
Great Novel Therapeutics Biotech & Medicals Corp. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.21M | -480.00K | -28.49% |
| Dec 31, 2024 | 1.69M | -3.17M | -65.26% |
| Dec 31, 2023 | 4.85M | 4.31M | 798.15% |
| Dec 31, 2022 | 540.00K | -90.00K | -14.29% |
| Dec 31, 2021 | 630.00K | 630.00K | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | -2.86M | -100.00% |
| Dec 31, 2018 | 2.86M | 2.85M | 28470.00% |
| Dec 31, 2017 | 10.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.